EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark CRISPR THERAPEUTICS was filed as Word mark on 10/11/2018 at the European Union Intellectual Property Office. The current status of the mark is "Application withdrawn".
| Trademark form | Word mark |
| File reference | 017967448 |
| Application date | October 11, 2018 |
Trademark representatives
8th Floor,
140 London Wall
EC2Y 5DN London
GB
goods and services
1
Stem cells for scientific and research purposes; reagents for scientific and research use; diagnostic preparations and reagents for scientific or research use; kits primarily composed of reagents for scientific and research use
5
Pharmaceutical and biopharmaceutical preparations, agents and substances; diagnostic reagents and assay components for clinical, medical and medical laboratory use; Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
9
Apparatus, equipment and instruments for scientific, laboratory, diagnostic or general research use; laboratory apparatus and instruments; laboratory apparatus and instruments for preparing and processing genetic materials in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; parts and fittings for the aforesaid goods
41
Education and training services; providing education in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
42
Science and technology services; medical and scientific research; pharmacological research services; laboratory services; gene editing; research and development of therapeutics using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting therapies to individuals; information, advisory and consultancy relating to the aforesaid services
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 27, 2020 | RAW: Conversion - Conversion of a EUTM into a national trade mark, Not to be published |
ID: 11017967448